Technology spillover as a complement for high-level R&D intensity in the pharmaceutical industry

Technovation

Volumn 22, Issue 4, 2002, Pages 245-258

  Watanabe, Chihiro ^a   Takayama, Makoto ^a   Nagamatsu, Akira ^a   Tagami, Takashi ^a   Griffy Brown, Charla ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Assimilation capacity; R D intensity of the pharmaceutical industry; Technology spillover

Indexed keywords

COMPETITIVE INTELLIGENCE; DRUG PRODUCTS PLANTS; PRODUCTIVITY; RESEARCH AND DEVELOPMENT MANAGEMENT; TECHNOLOGY TRANSFER;

TECHNOLOGY SPILLOVER;

DRUG PRODUCTS;

EID: 0036532699     PISSN: 01664972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4972(01)00004-9     Document Type: Article

References (8)

1. Innovation and learning: The two faces of R&D
2. Cost of innovation in the pharmaceutical industry
3. A new look at the returns and risks to pharmaceutical R&D
4. Returns to R&D on new drug introductions in the 1980s
5. Issues in assessing the contribution of R&D to productivity growth
6. Technological opportunity and spillovers of R&D: Evidence from firm's patents, profits and market value
7. Global technology spillover and its impact on industry's R&D strategies